Lördag 28 Juni | 07:15:23 Europe / Stockholm

Prenumeration

2025-06-27 18:18:00

Return gives its insights on the recently published PROPEL data. We are encouraged by the increasing clinical documentation and make minor positive revisions to our long-term estimates, resulting in an increased fair value range.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/